ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 526333 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 526333; 2) Community: the network communities that were significantly associated with the response to NSC 526333; 3) Molecule: the relationships between components within communities and NSC 526333; 4) MDR: the compounds that were significantly associated with the NSC 526333.

NSC Compound Enrichment Correlation
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0126882509540134 0.29166977
NSC 135880 Null 0.0126882509540134 0.55920836
NSC 148790 Card-20(22)-enolide, 16-(acetyloxy)-3,14-dihydroxy-, (3.beta.,5.beta.,16.beta.)- (9CI) 0.0126882509540134 0.22800034
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.0126882509540134 0.39942698
NSC 321240 Null 0.0126882509540134 0.30479021
NSC 32951 Acetic acid, (2,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone 0.0126882509540134 0.42291009
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0126882509540134 0.1047095
NSC 627687 Null 0.0133012546828912 0.42007195
NSC 642316 ANTINEOPLASTIC-642316 0.0133012546828912 0.14909673
NSC 646122 Null 0.0133012546828912 0.36091058
Total:114  Current:35    [First] [Prev] [Next] [Last]